Design, synthesis and structure-activity relationships of novel phenylalanine-based amino acids as kainate receptors ligands

被引:2
|
作者
Szymanska, Ewa [1 ]
Chalupnik, Paulina [1 ]
Szczepanska, Katarzyna [1 ]
Moral, Ana Maria Cunado [2 ]
Pickering, Darryl S. [2 ]
Nielsen, Birgitte [2 ]
Johansen, Tommy N. [2 ]
Kiec-Kononowicz, Katarzyna [1 ]
机构
[1] Jagiellonian Univ, Coll Med, Dept Technol & Biotechnol Drugs, Med 9, PL-30688 Krakow, Poland
[2] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen O, Denmark
关键词
Ionotropic glutamate receptors; Kainate receptors; GluK1; GluK3; Phenylalanine; GLUTAMATE RECEPTORS; PHARMACOLOGICAL CHARACTERIZATION; IN-VITRO; BINDING; ANTAGONISTS; DERIVATIVES; INHIBITORS; RESOLUTION; AFFINITY; CHANNEL;
D O I
10.1016/j.bmcl.2016.09.075
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of carboxyaryl-substituted phenylalanines was designed, synthesized and pharmacologically characterized in vitro at native rat ionotropic glutamate receptors as well as at cloned homomeric kainate receptors GluK1-GluK3. Among them, six compounds bound to GluK1 receptor subtypes with reasonable affinity (K-1 values in the range of 4.9-7.5 mu M). A structure-activity relationship (SAR) for the obtained series, focused mainly on the pharmacological effect of structural modifications in the 4- and 5-position of the phenylalanine ring, was established. To illustrate the results, molecular docking of the synthesized series to the X-ray structure of GluK1 ligand binding core was performed. The influence of individual substituents at the phenylalanine ring for both the affinity and selectivity at AMPA, GluK1 and GluK3 receptors was analyzed, giving directions for future studies. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5568 / 5572
页数:5
相关论文
共 50 条
  • [1] Novel Ligands for human melanocortin receptor subtypes: Design, synthesis and structure-activity relationships
    Stankova, Magda
    Cai, Minying
    Cabello, Chris
    DeCot, Bridgette
    Krchnak, Victor, Jr.
    Hruby, Victor J.
    [J]. PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 649 - 650
  • [2] Novel ligands for human melanocortin receptor subtypes: Design, synthesis and structure-activity relationships
    Stankova, M
    Cai, M
    Cabello, C
    DeCot, B
    Krchnak, V
    Hruby, VJ
    [J]. BIOPOLYMERS, 2003, 71 (03) : 309 - 309
  • [3] Halogenated ligands and their interactions with amino acids: Implications for structure-activity and structure-toxicity relationships
    Kortagere, Sandhya
    Ekins, Sean
    Welsh, William J.
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2008, 27 (02): : 170 - 177
  • [4] Design, synthesis, and structure-activity relationships of novel tetracyclic compounds as peripheral benzodiazepine receptor ligands
    Okubo, T
    Yoshikawa, R
    Chaki, S
    Okuyama, S
    Nakazato, A
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (13) : 3569 - 3580
  • [5] Design, synthesis and structure-activity relationships of novel strychnine-insensitive glycine receptor ligands
    Cordi, A
    Lacoste, JM
    Audinot, V
    Millan, M
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (10) : 1409 - 1414
  • [6] Design, synthesis and structure-activity relationships of novel ALS inhibitors
    Ren, TR
    Yang, HW
    Gao, X
    Yang, XL
    Zhou, JJ
    Cheng, FH
    [J]. PEST MANAGEMENT SCIENCE, 2000, 56 (03) : 218 - 226
  • [7] Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR α/γ agonists
    Zhang, Hao
    Ryono, Denis E.
    Devasthale, Pratik
    Wang, Wei
    O'Malley, Kevin
    Farrelly, Dennis
    Gu, Liqun
    Harrity, Thomas
    Cap, Michael
    Chu, Cuixia
    Locke, Kenneth
    Zhang, Litao
    Lippy, Jonathan
    Kunselman, Lori
    Morgan, Nathan
    Flynn, Neil
    Moore, Lisa
    Hosagrahara, Vinayak
    Zhang, Lisa
    Kadiyala, Pathanjali
    Xu, Carrie
    Doweyko, Arthur M.
    Bell, Aneka
    Chang, Chiehying
    Muckelbauer, Jodi
    Zahler, Robert
    Hariharan, Narayanan
    Cheng, Peter T. W.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (05) : 1451 - 1456
  • [8] Discovery of novel glitazones incorporated with phenylalanine and tyrosine: Synthesis, antidiabetic activity and structure-activity relationships
    Kumar, B. R. Prashantha
    Baig, Nasir R.
    Sudhir, Sai
    Kar, Koyal
    Kiranmai, M.
    Pankaj, M.
    Joghee, Nanjan M.
    [J]. BIOORGANIC CHEMISTRY, 2012, 45 : 12 - 28
  • [9] Rational design, synthesis, and pharmacological evaluation of a cohort of novel beta-adrenergic receptors ligands enables an assessment of structure-activity relationships
    Tricomi, Jacopo
    Landini, Luca
    Nieddu, Valentina
    Cavallaro, Ugo
    Baker, Jillian G.
    Papakyriakou, Athanasios
    Richichi, Barbara
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 246
  • [10] Design, synthesis, structure-activity relationships, and biological characterization of novel arylalkoxyphenylalkylamine σ ligands as potential antipsychotic drugs
    Nakazato, A
    Ohta, K
    Sekiguchi, Y
    Okuyama, S
    Chaki, S
    Kawashima, Y
    Hatayama, K
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (06) : 1076 - 1087